CClinicalTrials.gg
Status unknownNCT02124408Updated Apr 28, 2015

Mobile Phone Personalized Intervention for Diabetes

An interventional study of Personalized Behavioral Intervention in Diabetes Mellitus, sponsored by Ningbo Beilun District Traditional Chinese Medicine Hospital. Status unknown at 1 site in China. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2015-04-28.

Sponsored by Ningbo Beilun District Traditional Chinese Medicine Hospital · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Apr 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

With the development of economy and change of lifestyles, it is characterized that there is a dramatic increase of diabetes in China. Changes in lifestyle/self-care behaviors by diabetes patients are required to improve blood glucose and subsequent outcomes. Mobile phone intervention was a kind of high cost efficiency and high quality health care. Our study evaluated a diabetes coaching system, using mobile phones and patient/provider portals for patient-specific treatment and communication.

02

Conditions studied

  • Diabetes Mellitus

Browse trials for

03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 500 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

This is the only study on the registry with Ningbo Beilun District Traditional Chinese Medicine Hospital as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Physician diagnosis of type 2 diabetes
  2. Age 20 years and more
  3. The local resident

Exclusion criteria

Exclusion Criteria:

  1. Not currently managed by study physicians
  2. Pregnant
  3. Active substance, alcohol, or drug abuser
  4. Psychotic or schizophrenic under activecare
  5. Severe hearing or visual impairment
  6. No telephone or mobile phone
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Personalized Behavioral Intervention

    Behavioral: Personalized Behavioral Intervention

  • No intervention
    Control group

Interventions

  • BehavioralPersonalized Behavioral Intervention
06

What researchers measure

Primary outcomes

  1. change in glycated hemoglobin levels

    Blood sample would be collected and HbA1C level would be assessed in baseline and 6 months later.Change in glycated hemoglobin levels will be compared between the two group.

    Time frame: baseline and 6 months

Secondary outcomes

  1. changes in patient-reported diabetes symptoms

    Diabetes symptoms such as polydipsia, polyuria and polyphagia of all participants would be obtained by questionnaire in baseline and 6 months and compared between the two groups.

    Time frame: baseline and 6 months

  2. control of diabetic complications

    Blood pressure, blood lipid, weight and sleep quality etc.would be obtained by physical or lab examination or questionnaire in baseline and 6 months. The percentage of patients with well-control of blood pressure (BP≤130/80mmHg),weight (BMI≤24kg/m2) and sleep quality(PSQI score≤5) etc.will be compared between the two groups.

    Time frame: baseline and 6 months

07

Study locations

1 of 1 sites recruiting
  • Ningbo Beilun District Traditional Chinese Medicine Hospital
    Ningbo, Zhejiang 315800, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02124408
Lead sponsor
Ningbo Beilun District Traditional Chinese Medicine Hospital
Responsible party
Sponsor
First posted
Apr 28, 2014
Start date
Nov 2013
Primary completion
Dec 2015 (estimated)
Last update
Apr 28, 2015

Study contacts

Manhong Zhao, MD
Contact
zhaomanhong12@163.com
+86-574-86784207
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion